| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Eli Lilly is emphasizing the development of GLP-1 drugs, particularly in the weight-loss and diabetes medication sector. The innovative focus on next-generation products like retatrutide suggests strong potential for market impact, bolstered by positive clinical trial results. This strategic direction aligns with rising demand for obesity treatments and advanced therapies, showcasing significant growth opportunities. However, competitive pressures within the pharmaceutical landscape remain a challenge for sustaining momentum. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 0.6 is bullish. The market sentiment at 1 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. LLY is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1, and the negative at 0 on 2026-07-24. The forces of Sentiment towards Fundamentals (2.1), Valuation Sentiment (1.3), Market Risk Appetite (1.2), Option Sentiment (0.8), Stock Price Trend (0.6), Sector Price Trend (0.5), and Price Level Sentiment (0) will drive up the price. The forces of and Price Level Sentiment (0) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| LLY | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-24 | 0%(0%) | 1196.1 | 2.02% | 56 | 49 | 64 | 0.87% | 0.07% | 0.6 | 0.2 | 1.2% | 1 | Long | 55% | 2.1 | 7 |
| 2026-07-23 | 0%(0%) | 1185.77 | 2.33% | 49 | 45 | 71 | 1.95% | -0.26% | 0.2 | 0.3 | 0.9% | 1 | Long | 55% | 2.5 | 6.8 |
| 2026-07-22 | 0%(0.1%) | 1163.08 | 2.7% | 34 | 44 | 50 | -0.97% | -0.45% | -0.3 | -0.1 | 0.6% | 1 | Short | 55% | 2.5 | -1 |
| 2026-07-21 | 0%(0.1%) | 1174.52 | 3.01% | 46 | 45 | 52 | 2.42% | -0.51% | -0 | 0.4 | 0.8% | 1 | Long | 55% | 2.6 | -1 |
| 2026-07-20 | 0%(0.1%) | 1146.8 | 3.41% | 30 | 33 | 18 | -2.7% | -0.47% | -0.7 | -0.8 | 0.9% | 1.4 | Short | 55% | 3.6 | -1 |
| 2026-07-19 | 0%(0.1%) | -0.1 | -0.8 | 1.1 | 3.9 | -1 | ||||||||||
| 2026-07-18 | 0%(0.1%) | -0.1 | -0.8 | 1 | 3.9 | 4 | ||||||||||
| 2026-07-17 | 0%(0.1%) | 1178.58 | 3.59% | 52 | 44 | 51 | 0.71% | -0.27% | -0.1 | 0.1 | 1% | 1.1 | Long | 55% | 3.5 | 5.5 |
| 2026-07-16 | 1%(0.1%) | 1170.23 | 3.8% | 49 | 57 | 65 | 1.19% | -0.18% | -0.4 | -0.1 | 1.2% | 1.1 | Short | 55% | 2.6 | 5.8 |
| 2026-07-15 | 0%(0%) | 1156.47 | 3.95% | 43 | 57 | 58 | 0.17% | -0.35% | -0.8 | 0.2 | 1.4% | 0.5 | Wait | 50% | 1.8 | 6 |
| Long is the preferred trading strategy with 55% chance of being right. Improving trend sentiment and positive hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| Analysis | ||
| ● Eli Lilly (LLY) – Equity Research Report Tue. Mar 17, 2026 | ||
| 2026-07-24 17:02:39 Intensifying competition in the obesity treatment market between major players like Eli Lilly and Novo Nordisk reshapes market strategies and consumer options. |
| 2026-07-24 17:02:39 Recent stock performance suggests investor confidence in Eli Lilly, reflecting positive sentiment in financial reporting and growth prospects. |
| 2026-07-24 17:02:39 Analysts highlight Eli Lilly's strong market position and potential for growth driven by innovations and upcoming drug approvals. |
| 2026-07-24 17:02:39 The ongoing legal battles between Eli Lilly and Novo Nordisk regarding competitive marketing practices contribute to a sense of uncertainty and competition in the market. |
| 2026-07-24 17:02:39 The positive progress of Eli Lilly's obesity drug retatrutide, indicating potential regulatory approval and recognition of safety in recent studies, drives a favorable sentiment in the market. |
| 2026-07-24 15:47:20 The $128.7 million raised during the IPO represents significant investment growth and financial backing for Scribe Therapeutics. |
| 2026-07-24 15:47:20 The focus on developing gene therapies for heart diseases highlights advancements in healthcare and innovative treatment options. |
| 2026-07-24 15:47:20 The significant increase in stock value after a successful IPO indicates strong market interest and investor confidence in Scribe Therapeutics. |